1. Home
  2. UDMY vs AORT Comparison

UDMY vs AORT Comparison

Compare UDMY & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Udemy Inc.

UDMY

Udemy Inc.

HOLD

Current Price

$4.67

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$39.72

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UDMY
AORT
Founded
2009
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
2.1B
IPO Year
2021
1993

Fundamental Metrics

Financial Performance
Metric
UDMY
AORT
Price
$4.67
$39.72
Analyst Decision
Buy
Strong Buy
Analyst Count
10
5
Target Price
$9.00
$49.36
AVG Volume (30 Days)
2.3M
315.7K
Earning Date
02-05-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$789,844,000.00
$422,646,000.00
Revenue This Year
$2.34
$15.97
Revenue Next Year
$2.66
$10.96
P/E Ratio
$184.14
N/A
Revenue Growth
0.42
9.81
52 Week Low
$4.35
$21.97
52 Week High
$10.61
$48.25

Technical Indicators

Market Signals
Indicator
UDMY
AORT
Relative Strength Index (RSI) 36.58 36.77
Support Level $4.35 $39.08
Resistance Level $5.06 $41.97
Average True Range (ATR) 0.24 1.30
MACD -0.01 -0.13
Stochastic Oscillator 35.80 19.04

Price Performance

Historical Comparison
UDMY
AORT

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: